Adult obesity prevalence: male (age-standardized, %) vs DTP3 immunization coverage among 1-year-olds (%) in Andorra
In 2024, adult obesity prevalence: male (age-standardized, %) in Andorra stood at 18.8%, against 98% for DTP3 immunization coverage among 1-year-olds (%).
Change the pair
Compare different indicators
The series
Over time
Andorra, spaced by time. Both series are in %, so they share one axis; the legend names each line.
Adult obesity prevalence: male (age-standardized, %) and DTP3 immunization coverage among 1-year-olds (%)
Unit: % · 61 observations
Estimates are listed as such in the table below
View the underlying data
| Indicator | Period | Type | Value |
|---|---|---|---|
| Adult obesity prevalence: male (age-standardized, %) | 2024 | Estimate | 18.8% |
| Adult obesity prevalence: male (age-standardized, %) | 2023 | Estimate | 18.8% |
| Adult obesity prevalence: male (age-standardized, %) | 2022 | Estimate | 18.8% |
| Adult obesity prevalence: male (age-standardized, %) | 2021 | Estimate | 18.7% |
| Adult obesity prevalence: male (age-standardized, %) | 2020 | Estimate | 18.7% |
| Adult obesity prevalence: male (age-standardized, %) | 2019 | Estimate | 18.7% |
| Adult obesity prevalence: male (age-standardized, %) | 2018 | Estimate | 18.7% |
| Adult obesity prevalence: male (age-standardized, %) | 2017 | Estimate | 18.7% |
| Adult obesity prevalence: male (age-standardized, %) | 2016 | Estimate | 18.6% |
| Adult obesity prevalence: male (age-standardized, %) | 2015 | Estimate | 18.6% |
| Adult obesity prevalence: male (age-standardized, %) | 2014 | Estimate | 18.5% |
| Adult obesity prevalence: male (age-standardized, %) | 2013 | Estimate | 18.4% |
| Adult obesity prevalence: male (age-standardized, %) | 2012 | Estimate | 18.3% |
| Adult obesity prevalence: male (age-standardized, %) | 2011 | Estimate | 18.2% |
| Adult obesity prevalence: male (age-standardized, %) | 2010 | Estimate | 18% |
| Adult obesity prevalence: male (age-standardized, %) | 2009 | Estimate | 17.8% |
| Adult obesity prevalence: male (age-standardized, %) | 2008 | Estimate | 17.4% |
| Adult obesity prevalence: male (age-standardized, %) | 2007 | Estimate | 17.1% |
| Adult obesity prevalence: male (age-standardized, %) | 2006 | Estimate | 16.6% |
| Adult obesity prevalence: male (age-standardized, %) | 2005 | Estimate | 16.1% |
| Adult obesity prevalence: male (age-standardized, %) | 2004 | Estimate | 15.6% |
| Adult obesity prevalence: male (age-standardized, %) | 2003 | Estimate | 15.1% |
| Adult obesity prevalence: male (age-standardized, %) | 2002 | Estimate | 14.6% |
| Adult obesity prevalence: male (age-standardized, %) | 2001 | Estimate | 14.1% |
| Adult obesity prevalence: male (age-standardized, %) | 2000 | Estimate | 13.6% |
| Adult obesity prevalence: male (age-standardized, %) | 1999 | Estimate | 13% |
| Adult obesity prevalence: male (age-standardized, %) | 1998 | Estimate | 12.5% |
| Adult obesity prevalence: male (age-standardized, %) | 1997 | Estimate | 12.1% |
| Adult obesity prevalence: male (age-standardized, %) | 1996 | Estimate | 11.6% |
| Adult obesity prevalence: male (age-standardized, %) | 1995 | Estimate | 11.2% |
| Adult obesity prevalence: male (age-standardized, %) | 1994 | Estimate | 10.8% |
| Adult obesity prevalence: male (age-standardized, %) | 1993 | Estimate | 10.5% |
| Adult obesity prevalence: male (age-standardized, %) | 1992 | Estimate | 10.2% |
| Adult obesity prevalence: male (age-standardized, %) | 1991 | Estimate | 9.9% |
| Adult obesity prevalence: male (age-standardized, %) | 1990 | Estimate | 9.67% |
| DTP3 immunization coverage among 1-year-olds (%) | 2025 | Estimate | 98% |
| DTP3 immunization coverage among 1-year-olds (%) | 2024 | Estimate | 98% |
| DTP3 immunization coverage among 1-year-olds (%) | 2023 | Estimate | 98% |
| DTP3 immunization coverage among 1-year-olds (%) | 2022 | Estimate | 98% |
| DTP3 immunization coverage among 1-year-olds (%) | 2021 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2020 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2019 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2018 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2017 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2016 | Estimate | 98% |
| DTP3 immunization coverage among 1-year-olds (%) | 2015 | Estimate | 97% |
| DTP3 immunization coverage among 1-year-olds (%) | 2014 | Estimate | 97% |
| DTP3 immunization coverage among 1-year-olds (%) | 2013 | Estimate | 96% |
| DTP3 immunization coverage among 1-year-olds (%) | 2012 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2011 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2010 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2009 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2008 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2007 | Estimate | 96% |
| DTP3 immunization coverage among 1-year-olds (%) | 2006 | Estimate | 93% |
| DTP3 immunization coverage among 1-year-olds (%) | 2005 | Estimate | 98% |
| DTP3 immunization coverage among 1-year-olds (%) | 2004 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2003 | Estimate | 99% |
| DTP3 immunization coverage among 1-year-olds (%) | 2002 | Estimate | 97% |
| DTP3 immunization coverage among 1-year-olds (%) | 2001 | Estimate | 96% |
| DTP3 immunization coverage among 1-year-olds (%) | 2000 | Estimate | 98% |
Source: WHO · CC BY 4.0 · Adult obesity prevalence: male (age-standardized, %) · DTP3 immunization coverage among 1-year-olds (%)
Shared periods
Side by side
25 periods are published for both series in Andorra as annual figures on the same basis. Comparing anything else would mean comparing different periods.
| Period | Adult obesity prevalence: male (age-standardized, %) | DTP3 immunization coverage among 1-year-olds (%) |
|---|---|---|
| 2000 | 13.6% WHO | 98% WHO |
| 2001 | 14.1% WHO | 96% WHO |
| 2002 | 14.6% WHO | 97% WHO |
| 2003 | 15.1% WHO | 99% WHO |
| 2004 | 15.6% WHO | 99% WHO |
| 2005 | 16.1% WHO | 98% WHO |
| 2006 | 16.6% WHO | 93% WHO |
| 2007 | 17.1% WHO | 96% WHO |
| 2008 | 17.4% WHO | 99% WHO |
| 2009 | 17.8% WHO | 99% WHO |
| 2010 | 18% WHO | 99% WHO |
| 2011 | 18.2% WHO | 99% WHO |
| 2012 | 18.3% WHO | 99% WHO |
| 2013 | 18.4% WHO | 96% WHO |
| 2014 | 18.5% WHO | 97% WHO |
| 2015 | 18.6% WHO | 97% WHO |
| 2016 | 18.6% WHO | 98% WHO |
| 2017 | 18.7% WHO | 99% WHO |
| 2018 | 18.7% WHO | 99% WHO |
| 2019 | 18.7% WHO | 99% WHO |
| 2020 | 18.7% WHO | 99% WHO |
| 2021 | 18.7% WHO | 99% WHO |
| 2022 | 18.8% WHO | 98% WHO |
| 2023 | 18.8% WHO | 98% WHO |
| 2024 | 18.8% WHO | 98% WHO |
Provenance
Where these numbers come from
Adult obesity prevalence: male (age-standardized, %)
Percentage of male adults aged 18 and older with a body mass index (BMI) of 30 kg/m² or higher, age-standardized estimate.
35 observations charted in Andorra · source organisations: WHO
DTP3 immunization coverage among 1-year-olds (%)
The percentage of surviving infants who received three doses of diphtheria, tetanus toxoid and pertussis-containing vaccine in a given year, based on WHO/UNICEF Estimates of National Immunization Coverage (WUENIC).
26 observations charted in Andorra · source organisations: WHO
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring